ClinicalTrials.Veeva

Menu

Patient Blood Management - Use and Outcome (PBM-USZ)

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Hemorrhage

Study type

Observational

Funder types

Other

Identifiers

NCT02473666
KEK 2015-0175

Details and patient eligibility

About

Study the influence of transfusion related Patient Blood Management Program actions on transfusion-related outcome measures and cost.

Full description

At the University Hospital of Zurich, an in-house designed monitoring and feedback system was introduced which electronically registers each transfusion of any allogeneic blood product, be it red blood cells, plasma or platelets as well as corresponding laboratory data. Results are reported quarterly to Department heads. The investigator analyzes whether the introduction of this monitoring and feedback system as part of a patient blood management Program has a significant influence on use of allogeneic blood product transfusions and transfusion-related costs, without compromising patient outcome.

Enrollment

250,000 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Only case records, all discharged patients of the University Hospital of Zürich

Exclusion criteria

  • Not discharged from our Hospital.

Trial design

250,000 participants in 1 patient group

All Health Conditions.
Description:
All Health Conditions. Area of Focus: Transfusions of blood products.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems